Articles scientifiques

Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patient

Auteurs : Diamand R, Albisinni S
Année : 2022
Journal : Eur Urol Focus

The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma.

Auteurs : Rodríguez-Fraile M, Tamayo Alonso P, Rosales JJ, de Arcocha-Torres M, Caresia-Aróztegui AP, Cózar-Santiago MP, Orcajo-Rincon J, Simó Perdigó M, Delgado Bolton RC, Artigas C
Année : 2022
Journal : Rev Esp Med Nucl Imagen Mol (Engl Ed)
Volume : 41
Pages : 126-135

Tumor Cellularity and Infiltrating Lymphocytes (CelTIL) as a Survival Surrogate in HER2-Positive Breast Cancer.

Auteurs : Chic N, Luen SJ, Nuciforo P, Salgado R, Fumagalli D, Hilbers F, Wang Y, de Azambuja E, Làng I, Di Cosimo S, Saura C, Huober J, Prat A, Loi S
Année : 2022
Journal : J Natl Cancer Inst
Volume : 114(3)
Pages : 467-70

PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients.

Auteurs : Gueuning C, Ameye L, Loizidou A, Grigoriu B, Meert AP
Année : 2022
Journal : Support Care Cancer
Volume : 30
Pages : 7635-7643

When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.

Auteurs : Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van de Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V
Année : 2022
Journal : Bull Cancer
Volume : 109
Pages : 916-924

The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease.

Auteurs : AlGhamdi H, Dhont J, Krayem M, De Bruyn P, Engels B, Van Gestel D, Van den Begin R
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.

Auteurs : Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Martin R, Roumeguère T, Peltier A, Diamand R
Année : 2022
Journal : Prostate Cancer Prostatic Dis

Suburethral implantation of autologous regenerative cells for female stress urinary incontinence management: Results of a pilot study.

Auteurs : Maene A, Deniz G, Bouland C, Lagneaux L, Philippart P, Buxant F
Année : 2022
Journal : Eur J Obstet Gynecol Reprod Biol
Volume : 278
Pages : 38-44

An Atypical Behavior of Metastatic Lung Disease in a Young Woman With Osteosarcoma: A Case Report.

Auteurs : Acquisto A, Duran Derijckere I, De Angelis R
Année : 2022
Journal : Cureus
Volume : 14
Pages : e21589

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.

Auteurs : Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, Triulzi T, El-Abed S, Wang Y, Bajji M, Nuciforo P, Huober J, Ellard SL, Rimm DL, Gombos A, Daidone MG, Verderio P, Tagliabue E, Di Cosimo S, Iorio MV
Année : 2022
Journal : Cancer Med
Volume : 11
Pages : 332-339

Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?

Auteurs : Benkhaled S, Koshariuk O, Van Esch A, Remouchamps V
Année : 2022
Journal : Rep Pract Oncol Radiother
Volume : 27
Pages : 490-499

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progressio

Auteurs : Wildiers H, Meyskens T, Marréaud S, Lago LD, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Meulemans B, Sousa B, Poncet C, Brain E
Année : 2022
Journal : Breast
Volume : 64
Pages : 100-111

Cryobiopsy and dye marking guided by electromagnetic navigation bronchoscopy before resection of pulmonary nodule.

Auteurs : Taton O, Sokolow Y, Bondue B, Vandermeeren C, Kuylen MV, Gevenois PA, Remmelink M, Mekinda Ngono Z, Berghmans T, Leduc D
Année : 2022
Journal : Respir Med Res
Volume : 81
Pages : 100911

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.

Auteurs : Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G
Année : 2022
Journal : Eur Urol Oncol

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.

Auteurs : Bobin A, Kyheng M, Guidez S, Gruchet-Merouze C, Richez V, Duhamel A, Karlin L, Kolb B, Tiab M, Araujo C, Meuleman N, Malfuson JV, Bourquard P, Lenain P, Perrot A, Roussel M, Jaccard A, Petillon MO, Belhadj-Merzoug K, Chretien ML, Fontan J, Rodon P, Schmitt A, Offner F, Voillat L, Cereja S, Kuhnowski F, Rigaudeau S, Decaux O, Humbrecht-Kraut C, Frayfer J, Fitoussi O, Roos-Weil D, Eisenmann JC, Dorvaux V, Voog EG, Moreau P, Avet-Loiseau H, Hulin C, Facon T, Leleu X
Année : 2022
Journal : Leukemia
Volume : 36
Pages : 881-884

Temper the Specialist Nurses Heterogeneity in the Interest of Quality Practice and Mobility-18 EU Countries Study.

Auteurs : Decock N, Friganovic A, Kurtovic B, Oomen B, Crombez P, Willems C
Année : 2022
Journal : Healthcare (Basel)
Volume : 10

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.

Auteurs : Agostinetto E, Jacobs F, Debien V, De Caluwé A, Pop CF, Catteau X, Aftimos P, de Azambuja E, Buisseret L
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Efficacy of pharmacologic treatment for treating gastrointestinal angiodysplasias-related bleeding: a systematic review and meta-analysis.

Auteurs : Gkolfakis P, Fostier R, Tziatzios G, Lazaridis N, Fernandez Y Viesca M, Facciorusso A, Despott E, Triantafyllou K, Devière J, Arvanitakis M
Année : 2022
Journal : Eur J Gastroenterol Hepatol
Volume : 34
Pages : 1021-1030

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.

Auteurs : Zijlstra JM, Follows G, Casasnovas RO, Vermaat JSP, Kalakonda N, Choquet S, Hill B, Thieblemont C, Cavallo F, Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi P, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Xu J, Corona K, Chamoun K, Shah J, Canales M, Maerevoet M
Année : 2022
Journal : Cancers (Basel)
Volume : 14

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib.

Auteurs : Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, van Cutsem E
Année : 2022
Journal : Crit Rev Oncol Hematol
Volume : 169
Pages : 103564